Pursuant to Regulation 30 of the SEBI (LODR) Regulations, 2015, we are pleased to inform, that the Board of Directors of the Company at their Board Meeting held on Wednesday, November 13, 2024 interalia approved Un-Audited Financial Results (standalone and consolidated) for the 2nd quarter/ 1st half year ended September 30, 2024 of the FY 2024-25. Copy of the approved Un-Audited Financial Results (standalone and consolidated) for the 2nd quarter/ 1st half year ended September 30, 2024 of the FY 2024-25 alongwith the Limited Review report thereon are enclosed herewith.The Board meeting was started at 4:40 p.m. and concluded at 6:45 p.m.
Sunil Healthcare Ltd. Press Release Nov 13 2024
Filed with BSE ·
6ix hasn’t read this filing yet.
Earlier from Sunil Healthcare
Later from Sunil Healthcare
- Announcement under Regulation 30 (LODR)-Newspaper Publication
- Sunil Healthcare Ltd. Press Release Nov 15 2024
- Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
- Sunil Healthcare Ltd. Press Release Nov 22 2024
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Follow Sunil Healthcare into a list and get an email when it puts out news.
Follow Sunil Healthcare